University of Pennsylvania
Lanfranco Leo is a senior research investigator at the University of Pennsylvania since September 2023, previously serving as principal investigator at SwanBio Therapeutics from July 2020 to September 2023. At SwanBio, Lanfranco built and led AAV9 gene therapy pre-IND programs for rare neurological diseases, managing a team of scientists and composing research results for key stakeholders. Prior to this, Lanfranco held the position of translational research scientist at the University of Pennsylvania, where five independent AAV gene therapy programs were developed for ocular neurodegenerative diseases. With a Ph.D. in Neuroscience from Drexel University, a Master's in Pharmaceutical Biotechnology, and a Bachelor's in Biotechnology from Sapienza Università di Roma, Lanfranco has developed expertise in gene therapy, translational science, and neurodegeneration research throughout a diverse academic and professional career.
This person is not in any teams
University of Pennsylvania
40 followers
The University of Pennsylvania is one of the oldest universities in America and, as a member of the Ivy League, one of the most prestigious institutions of higher learning in all the world. Penn is home to 12 schools including the School of Arts and Sciences, the School of Nursing, the School of Engineering and Applied Science and the Wharton School of Business, as well as several graduate and professional schools such as the School of Medicine.